Filtered By:
Specialty: Complementary Medicine
Drug: Eloxatin
This page shows you your search results in order of date.
Order by Relevance | Date
Total 3 results found since Jan 2013.
The Antitumor Effect of TPD52L2 Silencing on Oxaliplatin-Resistant Gastric Carcinoma Is Related to Endoplasmic Reticulum Stress < em > In Vitro < /em >
Evid Based Complement Alternat Med. 2022 Jan 18;2022:4451178. doi: 10.1155/2022/4451178. eCollection 2022.ABSTRACTTumor protein D52-like 2 or simply TPD52L2 belongs to the TPD52 family which has been implicated in a variety of human carcinomas. However, the TPD52L2 function in the gastric carcinoma oxaliplatin (OXA) resistance remains elusive. The main objective of this study is to evaluate the TPD52L2 effect in OXA-resistant gastric carcinoma cells in vitro. Oxaliplatin-resistant gastric carcinoma cells were generated in MGC-803 and SGC-7901 cells. siRNA-mediated knockdown of TPD52L2 was investigated in OXA-resistant MGC-...
Source: Evidence-based Complementary and Alternative Medicine - January 28, 2022 Category: Complementary Medicine Authors: Yu Zhang Dejun Yang Ziran Wei Xin Zhang Zunqi Hu Hongbing Fu Jiapeng Xu Weijun Wang Source Type: research
